Literature DB >> 23756174

(4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone inhibits tubulin polymerization, induces G2/M arrest, and triggers apoptosis in human leukemia HL-60 cells.

Hemerson I F Magalhães1, Diego V Wilke, Daniel P Bezerra, Bruno C Cavalcanti, Rodrigo Rotta, Dênis P de Lima, Adilson Beatriz, Manoel O Moraes, Jairo Diniz-Filho, Claudia Pessoa.   

Abstract

(4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone (PHT) is a known cytotoxic compound belonging to the phenstatin family. However, the exact mechanism of action of PHT-induced cell death remains to be determined. The aim of this study was to investigate the mechanisms underlying PHT-induced cytotoxicity. We found that PHT displayed potent cytotoxicity in different tumor cell lines, showing IC50 values in the nanomolar range. Cell cycle arrest in G2/M phase along with the augmented metaphase cells was found. Cells treated with PHT also showed typical hallmarks of apoptosis such as cell shrinkage, chromatin condensation, phosphatidylserine exposure, increase of the caspase 3/7 and 8 activation, loss of mitochondrial membrane potential, and internucleosomal DNA fragmentation without affecting membrane integrity. Studies conducted with isolated tubulin and docking models confirmed that PHT binds to the colchicine site and interferes in the polymerization of microtubules. These results demonstrated that PHT inhibits tubulin polymerization, arrests cancer cells in G2/M phase of the cell cycle, and induces their apoptosis, exhibiting promising anticancer therapeutic potential.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone; 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide; 5-bromo-20-deoxyuridine; Apoptosis; BrdU; CA-4; CA-4P; Caspase activation; DI; MTT; PHT; Phenstatins; ROS; TNF-α; Tubulin inhibitors; combretastatin A-4; combretastatin-A4-phosphate; damage index; reactive oxygen species; tumor necrosis factor-α

Mesh:

Substances:

Year:  2013        PMID: 23756174     DOI: 10.1016/j.taap.2013.06.001

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  Effect of CPU-XT-008, a combretastatin A-4 analogue, on the proliferation, apoptosis and expression of vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein endothelial cells.

Authors:  Rui Xiong; Jing Sun; Kun Liu; Yungen Xu; Shuying He
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

2.  Investigation Into Environmental Selenium and Arsenic Levels and Arseniasis Prevalence in an Arsenic-Affected Coal-Burning Area.

Authors:  Ai-Mei Bai; Qian Li; Yue Li; Zhong-Xue Fan; Xiao-Qian Li; Wen-Hong Tan; Dong-Yuan Cao; Yi-Jun Kang
Journal:  Front Nutr       Date:  2022-06-20

3.  Nanoscale quantification of the biophysical characterization of combretastatin A-4-treated tumor cells using atomic force microscopy.

Authors:  Yanchun Li; Jv Chen; Yutong Liu; Weige Zhang; Wenhui He; Hanying Xu; Lianqing Liu; Enlong Ma
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

4.  Ru(II)-Thymine Complex Causes Cell Growth Inhibition and Induction of Caspase-Mediated Apoptosis in Human Promyelocytic Leukemia HL-60 Cells.

Authors:  Maiara de Souza Oliveira; Ádila Angélica Dantas de Santana; Rodrigo S Correa; Milena Botelho Pereira Soares; Alzir Azevedo Batista; Daniel Pereira Bezerra
Journal:  Int J Mol Sci       Date:  2018-05-30       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.